The University of Miami Miller School of Medicine has just launched a telemedicine program that provides doctors at Haiti’s only trauma, critical care and rehabilitation hospital with access to around-the-clock medical support through live video communication with UM trauma specialists.
News : 2014
When the American Society of Nephrology held its annual Kidney Week global conference in Philadelphia, the Center’s entire research team was in attendance because every one of their submissions had been accepted for presentation. Earlier in the month, the Center signed a $3.3 million contract with Swiss-based pharmaceutical giant Hoffmann-LaRoche for drug discovery related to two rare kidney diseases.
A team of international researchers, led by investigators at the Miller School of Medicine’s Department of Medicine and Diabetes Research Institute (DRI), has found that young capillary vessels can rejuvenate aged pancreatic islets. The study finding is significant because it suggests that targeting inflammation and fibrosis in the small blood vessels of the islet may offer new treatment options for type 2 diabetes.
Recently re-verified by the American Burn Association (ABA) and American College of Surgeons, the Burn Center at the University of Miami/Jackson Memorial Hospital remains one of only 63 burn centers in the nation and the only one in South Florida to earn the ABA’s highest honor. The Center’s verification will continue for another three-year cycle.
Practitioners from all over the world gathered last week at the Fontainebleau Miami Beach for the 38th annual Miami Neonatology conference, sponsored by the Miller School of Medicine and presented by the Department of Pediatrics’ Division of Neonatology. This year’s theme, “Advances in Respiratory Care,” featured two dozen of the field’s leading experts sharing the latest research and clinical knowledge.
A trio of Miller School of Medicine investigators has received a $4.9 million grant from the National Institutes of Health for a collaborative effort to move the search for novel treatments for diabetes to a new level. The grant, one of only four awarded, is a part of the Consortium on Human Islet Biomimetics, a group under the newly formed Human Islet Research Network.
Thirty-one students, faculty, staff, and alumni, including nine from the Miller School, were tapped last Wednesday and Thursday into the University of Miami Iron Arrow Honor Society.
Since 1973, Donald M. Buckner, M.D., has touched the lives of countless babies and their families as a skilled pediatric surgeon at the University of Miami/Jackson Memorial Hospital, where he has been an invaluable Miller School of Medicine faculty member. After 40 years of service, Buckner has retired.
Carl I. Schulman, M.D., Ph.D., M.S.P.H., professor of surgery in the Divisions of Trauma & Surgical Critical Care and Burns, has developed a lightweight, wireless, Android-based app to help medical responders in remote locations capture data during times of disaster.
Two University of Miami Miller School of Medicine researchers have been awarded funding from the Iacocca Foundation, a nationally renowned organization committed to funding innovative research in the hopes of finding a cure for type 1 diabetes.
In the first joint investment resulting from a novel public/private alliance, Integene International Holdings, a vascular biotechnology company led by Keith A. Webster, Ph.D., professor of molecular and cellular pharmacology and the Walter G. Ross Distinguished Chair in Vascular Biology, has received $600,000 in start-up capital.
In a deal that may lead to the first viable treatment for retinal diseases, Amarantus Bioscience Holdings, Inc., a biotechnology company, has exercised its exclusive right to license intellectual property related to a protein product developed by a researcher at the Miller School of Medicine’s Bascom Palmer Eye Institute.
Makinley Edwards, who turned 1 on June 14, is like lots of adorable baby girls. Just a few months ago, however, her prospects were grim. Shortly after her birth, Makinley was diagnosed with stage 3 hepatoblastoma — a form of liver cancer that tends to strike young children. Without the life-saving liver transplant she received at the Miami Transplant Institute, she never would have reached her first birthday.
At a dramatic news conference on July 17, the Miami Transplant Institute at the University of Miami/Jackson Memorial Medical Center announced the first successful three-way paired kidney exchange in the state of Florida. In the exchange, three families with a member needing a kidney transplant each found a match in one of the other families.
The National Institutes of Health announced the appointment of nine new members to the NIH Council of Councils, including the Miller School’s Norma Sue Kenyon, Ph.D., the Martin Kleiman Professor of Surgery, Microbiology and Immunology, and Biomedical Engineering, Chief Innovation Officer of the Miller School and Program Director of Novel Methods at the Miami Clinical and Translational Science Institute (CTSI).
An international research team led by investigators at the Miller School’s Diabetes Research Institute has developed a novel method of protecting diabetes-reversing islets that may prevent islet rejection or destruction by the immune system after they are transplanted in Type 1 diabetic patients.
An international team of researchers, including Miller School pulmonologist Marilyn K. Glassberg, M.D., has confirmed the results of earlier trials that pirfenidone, a medication already approved for use in nearly three dozen countries, is effective in slowing the progress of idiopathic pulmonary fibrosis. Their findings were published in the May 20 issue of The New England Journal of Medicine.
Message from Dean Goldschmidt: It is with great pride that I announce to you that our colleague Tomas A. Salerno, M.D., professor and Vice Chair of the Department of Surgery, has been elected Chair of the Faculty Senate. His one-year term will begin June 1.
Alan S. Livingstone, M.D., the Lucille and DeWitt Daughtry Professor and Chairman of Surgery, is usually addressed as “Dr. Livingstone,” sometimes as “Professor Livingstone.” Now there is a new option: “Your Excellency.” On March 27, Livingstone was inducted into Brazil’s National Academy of Medicine, one of the oldest and most exclusive medical academies in the world, and the title accompanies that honor.
Michael J. Goldstein, M.D., has been named director of kidney transplantation at the Miami Transplant Institute, a collaborative program between the Miller School of Medicine and Jackson Memorial Hospital. Goldstein also has been appointed Executive Director of the Life Alliance Organ Recovery Agency.